vs
NorthWestern Energy Group, Inc.（NWE）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是NorthWestern Energy Group, Inc.的1.6倍（$772.1M vs $497.6M），NorthWestern Energy Group, Inc.净利率更高（12.8% vs 12.7%，领先0.0%），NorthWestern Energy Group, Inc.同比增速更快（6.6% vs 5.9%），过去两年NorthWestern Energy Group, Inc.的营收复合增速更高（24.7% vs 9.0%）
西北能源集团（NorthWestern Energy Group, Inc.）是一家总部位于苏福尔斯的公用事业企业，业务覆盖南达科他州、内布拉斯加州和蒙大拿州。截至2019年，公司服务客户约71.8万户，集团总部设在苏福尔斯，南达科他州的运营总部则位于该州休伦市。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NWE vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.6倍
$497.6M
营收增速更快
NWE
高出0.8%
5.9%
净利率更高
NWE
高出0.0%
12.7%
两年增速更快
NWE
近两年复合增速
9.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $497.6M | $772.1M |
| 净利润 | $63.5M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 22.9% | 14.5% |
| 净利率 | 12.8% | 12.7% |
| 营收同比 | 6.6% | 5.9% |
| 净利润同比 | — | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NWERVTY
| Q1 26 | $497.6M | — | ||
| Q4 25 | $414.3M | $772.1M | ||
| Q3 25 | $387.0M | $698.9M | ||
| Q2 25 | $342.7M | $720.3M | ||
| Q1 25 | $466.6M | $664.8M | ||
| Q4 24 | $373.5M | $729.4M | ||
| Q3 24 | $345.2M | $684.0M | ||
| Q2 24 | $319.9M | $691.7M |
净利润NWERVTY
| Q1 26 | $63.5M | — | ||
| Q4 25 | $44.7M | $98.4M | ||
| Q3 25 | $38.2M | $46.7M | ||
| Q2 25 | $21.2M | $53.9M | ||
| Q1 25 | $76.9M | $42.2M | ||
| Q4 24 | $80.6M | $94.6M | ||
| Q3 24 | $46.8M | $94.4M | ||
| Q2 24 | $31.7M | $55.4M |
毛利率NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% |
营业利润率NWERVTY
| Q1 26 | 22.9% | — | ||
| Q4 25 | 14.5% | 14.5% | ||
| Q3 25 | 20.7% | 11.7% | ||
| Q2 25 | 17.7% | 12.6% | ||
| Q1 25 | 26.7% | 10.9% | ||
| Q4 24 | 24.6% | 16.3% | ||
| Q3 24 | 19.7% | 14.3% | ||
| Q2 24 | 19.3% | 12.4% |
净利率NWERVTY
| Q1 26 | 12.8% | — | ||
| Q4 25 | 10.8% | 12.7% | ||
| Q3 25 | 9.9% | 6.7% | ||
| Q2 25 | 6.2% | 7.5% | ||
| Q1 25 | 16.5% | 6.4% | ||
| Q4 24 | 21.6% | 13.0% | ||
| Q3 24 | 13.6% | 13.8% | ||
| Q2 24 | 9.9% | 8.0% |
每股收益（稀释后）NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $0.72 | $0.86 | ||
| Q3 25 | $0.62 | $0.40 | ||
| Q2 25 | $0.35 | $0.46 | ||
| Q1 25 | $1.25 | $0.35 | ||
| Q4 24 | $1.31 | $0.77 | ||
| Q3 24 | $0.76 | $0.77 | ||
| Q2 24 | $0.52 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $7.3B |
| 总资产 | — | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $8.8M | $919.9M | ||
| Q3 25 | $6.2M | $931.4M | ||
| Q2 25 | $2.9M | $991.8M | ||
| Q1 25 | $56.0M | $1.1B | ||
| Q4 24 | $4.3M | $1.2B | ||
| Q3 24 | $2.5M | $1.2B | ||
| Q2 24 | $6.4M | $2.0B |
总债务NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $7.3B | ||
| Q3 25 | $2.9B | $7.4B | ||
| Q2 25 | $2.9B | $7.6B | ||
| Q1 25 | $2.9B | $7.6B | ||
| Q4 24 | $2.9B | $7.7B | ||
| Q3 24 | $2.8B | $7.9B | ||
| Q2 24 | $2.8B | $7.9B |
总资产NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $8.5B | $12.2B | ||
| Q3 25 | $8.3B | $12.1B | ||
| Q2 25 | $8.1B | $12.4B | ||
| Q1 25 | $8.1B | $12.4B | ||
| Q4 24 | $8.0B | $12.4B | ||
| Q3 24 | $7.9B | $12.8B | ||
| Q2 24 | $7.7B | $13.4B |
负债/权益比NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | 1.14× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $56.2M | $182.0M | ||
| Q3 25 | $126.7M | $138.5M | ||
| Q2 25 | $58.2M | $134.3M | ||
| Q1 25 | $153.4M | $128.2M | ||
| Q4 24 | $62.8M | $174.2M | ||
| Q3 24 | $120.0M | $147.9M | ||
| Q2 24 | $62.3M | $158.6M |
自由现金流NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | $-93.7M | $161.8M | ||
| Q3 25 | $-26.9M | $120.0M | ||
| Q2 25 | $-70.6M | $115.5M | ||
| Q1 25 | $61.3M | $112.2M | ||
| Q4 24 | $-85.9M | $149.8M | ||
| Q3 24 | $-33.2M | $125.6M | ||
| Q2 24 | $-76.3M | $136.6M |
自由现金流率NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | -22.6% | 21.0% | ||
| Q3 25 | -6.9% | 17.2% | ||
| Q2 25 | -20.6% | 16.0% | ||
| Q1 25 | 13.1% | 16.9% | ||
| Q4 24 | -23.0% | 20.5% | ||
| Q3 24 | -9.6% | 18.4% | ||
| Q2 24 | -23.9% | 19.7% |
资本支出强度NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | 36.2% | 2.6% | ||
| Q3 25 | 39.7% | 2.6% | ||
| Q2 25 | 37.6% | 2.6% | ||
| Q1 25 | 19.7% | 2.4% | ||
| Q4 24 | 39.8% | 3.4% | ||
| Q3 24 | 44.4% | 3.3% | ||
| Q2 24 | 43.3% | 3.2% |
现金转化率NWERVTY
| Q1 26 | — | — | ||
| Q4 25 | 1.26× | 1.85× | ||
| Q3 25 | 3.31× | 2.97× | ||
| Q2 25 | 2.74× | 2.49× | ||
| Q1 25 | 1.99× | 3.03× | ||
| Q4 24 | 0.78× | 1.84× | ||
| Q3 24 | 2.56× | 1.57× | ||
| Q2 24 | 1.97× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NWE
| Electric | $362.1M | 73% |
| Gas | $135.5M | 27% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
